2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      IMPATIENT-qPCR: monitoring SELEX success during in vitro aptamer evolution

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abstract

          SELEX (Systematic Evolution of Ligands by Exponential enrichment) processes aim on the evolution of high-affinity aptamers as binding entities in diagnostics and biosensing. Aptamers can represent game-changers as constituents of diagnostic assays for the management of instantly occurring infectious diseases or other health threats. Without in-process quality control measures SELEX suffers from low overall success rates. We present a quantitative PCR method for fast and easy quantification of aptamers bound to their targets. Simultaneous determination of melting temperatures ( T m) of each SELEX round delivers information on the evolutionary success via the correlation of increasing GC content and T m alone with a round-wise increase of aptamer affinity to the respective target. Based on nine successful and published previous SELEX processes, in which the evolution/selection of aptamer affinity/specificity was demonstrated, we here show the functionality of the IMPATIENT-qPCR for polyclonal aptamer libraries and resulting individual aptamers. Based on the ease of this new evolution quality control, we hope to introduce it as a valuable tool to accelerate SELEX processes in general.

          IMPATIENT-qPCR SELEX success monitoring. Selection and evolution of high-affinity aptamers using SELEX technology with direct aptamer evolution monitoring using melting curve shifting analyses to higher T m by quantitative PCR with fluorescence dye SYBR Green I.

          Key points

          • Fast and easy analysis.

          • Universal applicability shown for a series of real successful projects.

          Graphical Abstract

          Related collections

          Most cited references30

          • Record: found
          • Abstract: not found
          • Article: not found

          Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            In vitro selection of RNA molecules that bind specific ligands.

            Subpopulations of RNA molecules that bind specifically to a variety of organic dyes have been isolated from a population of random sequence RNA molecules. Roughly one in 10(10) random sequence RNA molecules folds in such a way as to create a specific binding site for small ligands.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Development of DNA aptamers using Cell-SELEX.

              In the past two decades, high-affinity nucleic acid aptamers have been developed for a wide variety of pure molecules and complex systems such as live cells. Conceptually, aptamers are developed by an evolutionary process, whereby, as selection progresses, sequences with a certain conformation capable of binding to the target of interest emerge and dominate the pool. This protocol, cell-SELEX (systematic evolution of ligands by exponential enrichment), is a method that can generate DNA aptamers that can bind specifically to a cell type of interest. Commonly, a cancer cell line is used as the target to generate aptamers that can differentiate that cell type from other cancers or normal cells. A single-stranded DNA (ssDNA) library pool is incubated with the target cells. Nonbinding sequences are washed off and bound sequences are recovered from the cells by heating cell-DNA complexes at 95 degrees C, followed by centrifugation. The recovered pool is incubated with the control cell line to filter out the sequences that bind to common molecules on both the target and the control, leading to the enrichment of specific binders to the target. Binding sequences are amplified by PCR using fluorescein isothiocyanate-labeled sense and biotin-labeled antisense primers. This is followed by removal of antisense strands to generate an ssDNA pool for subsequent rounds of selection. The enrichment of the selected pools is monitored by flow cytometry binding assays, with selected pools having increased fluorescence compared with the unselected DNA library. The procedure, from design of oligonucleotides to enrichment of the selected pools, takes approximately 3 months.
                Bookmark

                Author and article information

                Contributors
                frank.rosenau@uni-ulm.de
                Journal
                Appl Microbiol Biotechnol
                Appl Microbiol Biotechnol
                Applied Microbiology and Biotechnology
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0175-7598
                1432-0614
                4 April 2024
                4 April 2024
                2024
                : 108
                : 1
                : 284
                Affiliations
                [1 ]Institute of Pharmaceutical Biotechnology, Ulm University, ( https://ror.org/032000t02) Albert-Einstein-Allee 11, 89081 Ulm, Germany
                [2 ]Max Planck Institute for Polymer Research Mainz, ( https://ror.org/00sb7hc59) Ackermannweg 10, 55128 Mainz, Germany
                [3 ]Institute of Experimental Physics, Ulm University, ( https://ror.org/032000t02) Albert-Einstein-Allee 11, 89081 Ulm, Germany
                [4 ]GRID grid.4332.6, ISNI 0000 0000 9799 7097, AIT Austrian Institute of Technology GmbH, ; Giefinggasse 4, 1210 Vienna, Austria
                Author information
                http://orcid.org/0000-0002-9297-6419
                Article
                13085
                10.1007/s00253-024-13085-7
                10995058
                38573322
                58f047a2-77be-456e-8f70-4f232a4826b2
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 8 November 2023
                : 7 February 2024
                : 19 February 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100010661, Horizon 2020 Framework Programme;
                Award ID: 686271
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft;
                Award ID: 465229237
                Award Recipient :
                Funded by: Universität Ulm (1055)
                Categories
                Applied Genetics and Molecular Biotechnology
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2024

                Biotechnology
                aptamer,selex,qpcr
                Biotechnology
                aptamer, selex, qpcr

                Comments

                Comment on this article